In this video, Sparta's VP of digital innovation Steve McCarthy explains five ways quality teams can decrease costs and increase profitability
Times are changing. Increasing competition, regulatory scrutiny and tightening margins are a few of the challenges facing Life Sciences Companies. As a result, drug and device manufacturers are evaluating every aspect of their operations to identify opportunities for greater efficiency and productivity.
If your company is among those that rely on paper or point solutions, here are three reasons to consider an integrated quality management software system.
In this second part, we continue our interview with Bruce Kratz and Jon Ragati, homing in on FDA requirements, making the transition to cloud QMS, and the long-term outlook.
Analysts predict that by 2020, there will be more than 50 billion connected devices, impacting industry and our daily lives. From mobile devices and wearable technology to cloud computing and IoT platforms, think about the data being generated and how it’s being leveraged to gain business insights and create new customer experiences.
Compliance is king. At least it has been for decades as far as quality teams at pharmaceutical and medical device companies are concerned. And now, FDA, is taking an emboldened step with another autocratic change.